Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL
Clinical trial NCT01173679 · TERMINATED
Trial details
- NCT number
- NCT01173679
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2015-01-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.